Näytä suppeat kuvailutiedot

dc.contributor.authorKwok, Janell
dc.contributor.authorKhanolainen, Daria P.
dc.contributor.authorSpeyer, Lydia Gabriela
dc.contributor.authorMurray, Aja Louise
dc.contributor.authorTorppa, Minna P.
dc.contributor.authorAuyeung, Bonnie
dc.date.accessioned2023-10-18T11:38:08Z
dc.date.available2023-10-18T11:38:08Z
dc.date.issued2023
dc.identifier.citationKwok, J., Khanolainen, D. P., Speyer, L. G., Murray, A. L., Torppa, M. P., & Auyeung, B. (2023). Examining maternal cardiometabolic markers in pregnancy on child emotional and behaviour trajectories : using growth curve models on a cohort study. <i>Biological Psychiatry Global Open Science</i>, <i>3</i>(4), 614-622. <a href="https://doi.org/10.1016/j.bpsgos.2023.08.004" target="_blank">https://doi.org/10.1016/j.bpsgos.2023.08.004</a>
dc.identifier.otherCONVID_184249834
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/90117
dc.description.abstractBackground Poor maternal cardiometabolic health in pregnancy is associated with negative effects on child health outcomes, but there is limited literature on child and adolescent socio-emotional outcomes. The study aims to investigate associations between maternal cardiometabolic markers during pregnancy with child and adolescence socio-emotional trajectories. Methods Growth curve models were run to examine how maternal cardiometabolic markers in pregnancy affected child socio-emotional trajectories from age 4 to 16. Models were adjusted for all pregnancy trimesters, maternal, child, and socioeconomic covariates. This study used the Avon Longitudinal Study of Parents and Children (United Kingdom) cohort. Participants consisted of mother-child pairs (n=15,133). Maternal predictors of fasting glucose, triglycerides, high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), and body mass index (BMI) were taken from each pregnancy trimester (T1, T2, T3). Child outcomes included emotional problems, conduct problems, and hyperactivity problems from the Strengths and Difficulties Questionnaire (SDQ). Results Fully adjusted models showed significant associations between elevated T1 fasting glucose and increased conduct problems, higher T1 BMI and increased hyperactivity problems, lowered T1 HDL and decreased hyperactivity problems, and elevated T2 triglycerides and increased hyperactivity problems. Conclusions Maternal cardiometabolic risk is associated with conduct and hyperactivity outcomes from age 4 to 16. This study suggests that maternal markers of fasting glucose, LDL, HDL, and triglycerides during pregnancy could be added as supplements for clinical measures of risk when predicting child and adolescence’s socio-emotional trajectories.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesBiological Psychiatry Global Open Science
dc.rightsCC BY 4.0
dc.subject.otherpregnancy
dc.subject.otherbiomarkers
dc.subject.otherchild development
dc.subject.othermetabolic
dc.subject.otherALSPAC
dc.titleExamining maternal cardiometabolic markers in pregnancy on child emotional and behaviour trajectories : using growth curve models on a cohort study
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202310186155
dc.contributor.laitosOpettajankoulutuslaitosfi
dc.contributor.laitosDepartment of Teacher Educationen
dc.contributor.oppiaineKasvatuspsykologiafi
dc.contributor.oppiaineResurssiviisausyhteisöfi
dc.contributor.oppiaineHyvinvoinnin tutkimuksen yhteisöfi
dc.contributor.oppiaineKasvatuspsykologiaen
dc.contributor.oppiaineSchool of Resource Wisdomen
dc.contributor.oppiaineSchool of Wellbeingen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.format.pagerange614-622
dc.relation.issn2667-1743
dc.relation.numberinseries4
dc.relation.volume3
dc.type.versionpublishedVersion
dc.rights.copyright© 2023 THE AUTHORS. Published by Elsevier Inc on behalf of the Society of Biological Psychiatry
dc.rights.accesslevelopenAccessfi
dc.relation.grantnumber813546
dc.relation.grantnumber813546
dc.relation.projectidinfo:eu-repo/grantAgreement/EC/H2020/813546/EU//Neo-PRISM-C
dc.subject.ysokäyttäytyminen
dc.subject.ysosydän- ja verisuonitaudit
dc.subject.ysososiaalinen kehitys
dc.subject.ysopsyykkinen kehitys
dc.subject.ysotunne-elämän kehitys
dc.subject.ysolapsen kehitys
dc.subject.ysoaineenvaihdunta
dc.subject.ysobiomarkkerit
dc.subject.ysoraskaus
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p3625
jyx.subject.urihttp://www.yso.fi/onto/yso/p9886
jyx.subject.urihttp://www.yso.fi/onto/yso/p6138
jyx.subject.urihttp://www.yso.fi/onto/yso/p2124
jyx.subject.urihttp://www.yso.fi/onto/yso/p12114
jyx.subject.urihttp://www.yso.fi/onto/yso/p2125
jyx.subject.urihttp://www.yso.fi/onto/yso/p3066
jyx.subject.urihttp://www.yso.fi/onto/yso/p12288
jyx.subject.urihttp://www.yso.fi/onto/yso/p8749
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.1016/j.bpsgos.2023.08.004
dc.relation.funderEuropean Commissionen
dc.relation.funderEuroopan komissiofi
jyx.fundingprogramMSCA Innovative Training Networks (ITN)en
jyx.fundingprogramMSCA Innovative Training Networks (ITN)fi
jyx.fundinginformationThe study’s interpretation of data and manuscript writing was supported by the following body throughout the course of this project: the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 813546. The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC’s design of the study and data collection.
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY 4.0